Duarte J, Fernandez-Caleya D, Alvarez-Valdivielso J M, Romero C, Desco M M, Cano M, Rodriguez F, Rubio M A, Antoranz J C, Del Cañizo J F
Department of Cardiovascular Surgery, Hospital de la Princesa, Madrid, Spain.
Eur J Cardiothorac Surg. 1991;5(1):46-50. doi: 10.1016/1010-7940(91)90083-v.
We report on the first human implantation of the BCM 3.5 ventricular assist device in a 46-year-old man suffering from terminal stage cardiomyopathy. The circulatory support was used as a bridge to heart transplantation. The patient was in cardiogenic shock and was on assisted circulation for 18 days after which he underwent cardiac transplantation. While receiving support from the ventricular assist device, the patient's condition improved remarkably and 50 days after transplantation he was discharged from hospital. We give a detailed description of the surgical technique, with special emphasis on the procedures for air extraction. We describe the evolution of the hemodynamic status before and after implantation. Final inspection of the device and cannulae after removal showed no thrombi and only small fibrin deposits in the membrane-wall junction.
我们报告首例将BCM 3.5心室辅助装置植入一名患有终末期心肌病的46岁男性体内的情况。循环支持被用作心脏移植的桥梁。患者处于心源性休克状态，接受辅助循环18天后接受了心脏移植。在接受心室辅助装置支持期间，患者的病情显著改善，移植后50天出院。我们详细描述了手术技术，特别强调了空气抽取程序。我们描述了植入前后血流动力学状态的变化。取出装置和插管后的最终检查显示没有血栓，仅在膜壁交界处有少量纤维蛋白沉积。
